Frontiers in Oncology (Oct 2021)
Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL
- Yuan Meng,
- Biping Deng,
- Luan Rong,
- Chuo Li,
- Weiliang Song,
- Zhuojun Ling,
- Jinlong Xu,
- Jiajia Duan,
- Zelin Wang,
- Alex H. Chang,
- Xiaoming Feng,
- Xiujuan Xiong,
- Xiaoli Chen,
- Jing Pan,
- Jing Pan
Affiliations
- Yuan Meng
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
- Biping Deng
- Cytology Laboratory, Beijing Boren Hospital, Beijing, China
- Luan Rong
- Cytology Laboratory, Beijing Boren Hospital, Beijing, China
- Chuo Li
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
- Weiliang Song
- Department of Hematology, Beijing Boren Hospital, Beijing, China
- Zhuojun Ling
- Department of Hematology, Beijing Boren Hospital, Beijing, China
- Jinlong Xu
- Department of Hematology, Beijing Boren Hospital, Beijing, China
- Jiajia Duan
- Department of Hematology, Beijing Boren Hospital, Beijing, China
- Zelin Wang
- Department of Hematology, Beijing Boren Hospital, Beijing, China
- Alex H. Chang
- Clinical Translational Research Center, Tongji University School of Medicine, Shanghai, China
- Xiaoming Feng
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
- Xiujuan Xiong
- Department of Pathology, Basic Medical College of Nanchang University, Nanchang, China
- Xiaoli Chen
- Ganzhou Key Laboratory of Molecular Medicine, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China
- Jing Pan
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
- Jing Pan
- State Key Laboratory of Experimental Hematology, Boren Clinical Translational Center, Department of Hematology, Beijing Boren Hospital, Beijing, China
- DOI
- https://doi.org/10.3389/fonc.2021.778039
- Journal volume & issue
-
Vol. 11
